Andelyn Biosciences Moves Forward With AAV9-GM2 Gene Therapy
Columbus, Ohio, August 18, 2026 Andelyn Biosciences, Inc., a patient-focused cell and gene therapy contract development and manufacturing organization...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Columbus, Ohio, August 18, 2026 Andelyn Biosciences, Inc., a patient-focused cell and gene therapy contract development and manufacturing organization...
New Brunswick, New Jersey, August 18, 2026 Johnson & Johnson has published a new Future of Digital Surgery report...
